2 terminated. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Terminated 2 |
| Phase 2 | 1 | Terminated 1 |
Follow Kidney Failure: new trials by email Literature Review of Kidney Failure trials Research Report on Kidney Failure
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Patient-Derived Stem Cell Therapy for Diabetic Kidney Disease Autologous adipose-derived mesenchymal stem/stromal cells (MSC) Lower Dose, Autologous adipose-derived mesenchymal stem/stromal cells (MSC) Higher Dose - Diabetic Kidney Disease, Diabetic Nephropathies | Phase 1 | Terminated | Mayo Clinic | 2 | 2019-10-23 | 2025-08-17 |
| An Open-Label Study To Assess The Pharmacokinetics, Safety And Toleration Of Vfend®; Following Multiple Dosing With Vfend Vfend®; I.V. - Kidney Failure | Phase 1 / Phase 2 | Terminated | Pfizer | 1 | 2005-06-01 | 2008-09-29 |
Renal Insufficiency (2) · Diabetes Mellitus, Type 1 (1) · Diabetes Mellitus, Type 2 (1) · Diabetic Nephropathies (1) · Renal Insufficiency, Chronic (1)
Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Kidney Diseases (2) · Male Urogenital Diseases (2) · Urogenital Diseases (2) · Urologic Diseases (2) · Autoimmune Diseases (1) · Chronic Disease (1) · Diabetes Complications (1) · Diabetes Mellitus (1) · Disease Attributes (1) · Endocrine System Diseases (1) · Glucose Metabolism Disorders (1) · Immune System Diseases (1) · Metabolic Diseases (1)
Voriconazole (1)
Mayo Clinic (1) · Pfizer (1)
United States (2)